An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• status post breast cancer or status post another type of cancer or status post no cancer

• chronic lymphedema - lymphedema lasting over three months - present prior to surgical treatment

• one type of surgical procedure for treatment of chronic lymphedema or a combination of surgical procedures for treatment of chronic lymphedema was performed

• one or any combination of the following surgical procedures was used in each individual patient: Lymph Node-Vein Anastomosis (LNVA) , Lymphaticovenous Anastomosis (LVA), Tumescent Liposuction (TL), Vascularized Lymph Node Transfer (VLNT) and/or Water-Assisted Liposuction (WAL)

Locations
Other Locations
Switzerland
University Hospital Basel
RECRUITING
Basel
Contact Information
Primary
Elisabeth A Kappos, PD Dr. med
elisabeth.kappos@usb.ch
0041 61 265 25 25
Backup
Adriano Fabi, BMed
adriano.fabi@uzh.ch
0041 79 888 12 51
Time Frame
Start Date: 2015-01-02
Estimated Completion Date: 2035-12-31
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland
Collaborators: Sana Kliniken Düsseldorf GmbH

This content was sourced from clinicaltrials.gov